HYKU BIO

Pharmaceutical preparations for targeting nucleophilic amino acid residues in proteins involved in human diseases, namely, cancer and for the treatment of human diseases, namely, cancer

Research and development in the field of covalent inhibitors targeting nucleophilic amino acid residues in proteins involved in human diseases, namely, cancer